Literature DB >> 17376012

Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder.

Arun Kunwar1, Mantosh Dewan, Stephen V Faraone.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) often occurs along with other psychiatric disorders, with estimated comorbidity rates of 50--90%. Comorbidity greatly influences presentation, diagnosis and prognosis, complicates treatment and significantly increases the morbidity and disease burden of ADHD. Commonly co-occurring psychiatric disorders are disruptive behavior disorder, anxiety, depression, bipolar disorder and substance use disorders. This article provides a brief review of effective strategies for treating the most common psychiatric disorders associated with ADHD. This paper also discusses knowledge gaps in the understanding of treatment of comorbid disorders associated with ADHD, and directions for future research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376012     DOI: 10.1517/14656566.8.5.555

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  7 in total

1.  Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study.

Authors:  Kouichi Yoshimasu; William J Barbaresi; Robert C Colligan; Robert G Voigt; Jill M Killian; Amy L Weaver; Slavica K Katusic
Journal:  J Child Psychol Psychiatry       Date:  2012-05-31       Impact factor: 8.982

2.  Diagnosing and managing complicated ADHD.

Authors:  Robert L Findling; L Eugene Arnold; Laurence L Greenhill; Christopher J Kratochvil; James J McGough
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

3.  Transdermal nicotine in adult ADHD with depression and anxiety.

Authors:  James A Cocores
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine.

Authors:  Timothy E Wilens; Lenard A Adler; Yoko Tanaka; Feng Xiao; Deborah N D'Souza; Stephen W Gutkin; Himanshu P Upadhyaya
Journal:  Curr Med Res Opin       Date:  2011-10-27       Impact factor: 2.580

Review 5.  Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review.

Authors:  Shari L Hutchison; Jaswinder K Ghuman; Harinder S Ghuman; Irina Karpov; James M Schuster
Journal:  Ther Adv Psychopharmacol       Date:  2016-05-20

6.  Use of SSRIs among Danish children: a nationwide study.

Authors:  Anton Pottegård; Helga Zoëga; Jesper Hallas; Per Damkier
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-02-04       Impact factor: 4.785

Review 7.  Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions.

Authors:  Grazia Dell'Agnello; Alessandro Zuddas; Gabriele Masi; Paolo Curatolo; Dante Besana; Andrea Rossi
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.